Construction and immunogenicity of multiple-epitope DNA vaccine against HIV

Chinese Journal of Biologicals

Volumn 20, Issue 3, 2007, Pages 178-180

  Li, Zhen ^a   Jin, Ning Yi ^b   Jin, Hong Tao ^b  

^a JILIN UNIVERSITY   (China)

^b NONE

Author keywords

DNA vaccine; Human immunodeficiency virus(HIV); Multiple epitope antigen

Indexed keywords

DNA VACCINE; EPITOPE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ARTICLE; BAGG ALBINO MOUSE; CELLULAR IMMUNITY; DNA SEQUENCE; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC RECOMBINATION; GENETIC TRANSFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; LYMPHOCYTE COUNT; MOUSE; NONHUMAN; RECOMBINANT PLASMID; RESTRICTION MAPPING; T LYMPHOCYTE; VACCINE PRODUCTION;

HUMAN IMMUNODEFICIENCY VIRUS; MUS;

EID: 77953386704     PISSN: 10045503     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Garber DA, Silvestri G, Feinberg MB. Prospects for an AIDS vaccine: thress big question, no easy answers. Lancet, 2004, 4 (6): 397-408.
2. Strayer DS, Akkina R, Bunnell BA, et al. Current status of gene therapy strategies to treat HIV/AIDS. Molecular Therapy, 2005, 11 (6):823-830.
3. Chinese source.
4. Giri M, Ugen KE, Weiner DB. DNA vaccines against human immunodeficiency virus type 1 in the past decade. Clin Microbiol Rev, 2004,17(2):370-389.
5. Chinese source.